Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Biotin in ALS
NCT03427086Phase 2Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- Jan 2018
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of biotin in amyotrophic lateral sclerosis (ALS), sponsored by American University of Beirut Medical Center. Started Jan 2018; status: completed.
02
Drugs
biotin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03427086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03427086.